To include your compound in the COVID-19 Resource Center, submit it here.

QGC101: Phase IIa started

Quantum Genomics began the double-blind, placebo-controlled, European Phase IIa QUID HF trial to

Read the full 131 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE